Accumulating evidences indicated that several signalling pathway‐related mutations including BRAFV600E, RAS, FGFR2, and SMO were synergistically contributed to the AM progression.24, 25, 26, 27, 28. Here, SMO is linked to acute myeloblastic leukemia with maturation.